Industrial Manslaughter Offences Now Passed in all Australian States and Territories
Key Takeaways: Industrial Manslaughter offences have now been passed in all Australian States and Territories. The stakes for officers and businesses in breaching safety laws have risen substantially in light of these reforms. Maximum penalties include up to life imprisonment for individuals and $20,000,000 for a Person Conducting a Business or Undertaking (PCBU). There is no consistency in Industrial […]
Australia’s Privacy Act Reforms – The beginning but (hopefully) not the end
“The Privacy and Other Legislation Amendment Bill 2024 is a significant step forward for Australian privacy law. It begins the much-needed work of updating our privacy laws to be fit-for-purpose in the digital age.” The Hon Mark Dreyfus KC MP, Second Reading Speech, 12 September 2024 There is no question that Australia’s Privacy Act is […]
SAFE Notes: not so safe after all?
Simple Agreements for Future Equity (SAFEs) have become a popular capital raising tool for companies and in particular, start-ups, since their inception a decade ago. Although designed to enable companies access to early-stage capital without the complexity of traditional debt and equity mechanics, SAFEs can often prove to be a far-cry from “simple”, as the […]
Key Considerations and Disclosure Challenges in Contested Scrip Takeovers
In M&A transactions, scrip deals are often used by bidders as they allow the target shareholders to retain part or full exposure to the underlying business and can be helpful in bridging the gap in value expectations, while reducing upfront cash paid by the bidder. As part of disclosure to target shareholders, it is customary […]
Section 641 in Action: Navigating the Early Stages of a Hostile Takeover
While schemes of arrangement remain the dominant structure used in public M&A transactions, there has been a resurgence of takeover bids in recent years. We expect to continue to see hostile takeovers in circumstances where bidders make ‘opportunistic’ offers in a lower priced market and misalignment between the bidder and target valuation expectations. Some would […]
Hamilton Locke Act on the Sale of Scentia Pty Ltd
Hamilton Locke is delighted to have advised on the $98,000,000 sale of Scentia Pty Ltd (Scentia) to Next Capital Pty Limited and The Silverfern Group. Scentia was established in 2015 and is a leading Australian education and training group which includes the Australian Institute of Management and the Australasian College of Health and Wellness. Commenting […]
Hamilton Locke advised Tryptamine Therapeutics Limited on its acquisition and backdoor listing of Tryp Therapeutics
Hamilton Locke advised Tryptamine Therapeutics Limited (previously Exopharm Limited) (Company) on its acquisition and backdoor listing of Tryp Therapeutics Inc., a biotechnology entity previously listed on the Canadian Securities Exchange. The acquisition occurred by way of a Canadian plan of arrangement and included a A$6,500,000 public offer. The Company is entering an exciting new field […]
7 Key Steps to Sell Your Business to Private Equity in Australia
Private capital markets have outperformed public equities in recent years, leading to an increase in asset allocation to private capital classes in Australia. Whilst M&A transaction volumes have remained depressed post-COVID-19, there remains a significant amount of ‘dry powder’ in the private equity sector waiting to be deployed. There are signs of green shoots in […]
The Role of WHS in Managing Risks to Workers Exacerbated by Climate Change
Climate change is exposing workers to significant health and safety risks by exacerbating existing climate-related hazards. As the challenge of climate change continues to unfold, businesses may be required to adapt their operations to ensure the continued health and safety of workers. Critically, businesses must adhere to WHS law and policy as the primary measure […]
ASX Compliance Update
Changes to ASX Listing Applications In a bid to enhance efficiency and clarity in the listing application process, the Australian Securities Exchange (ASX) has introduced several changes to its admission procedures, effective February 5, 2024. These changes set out in Compliance Update (no. 01/24) aim to simplify documentation requirements and improve compliance with spread and escrow […]
M&A Report: 2023 Year in Review and Future Outlook
In Mergermarket’s 2023 Global & Regional M&A Rankings, Hamilton Locke ranked 6th in Australia for the highest volume of M&A deals, with 69 deals valued at USD738 million. This is the firm’s highest Mergermarket ranking and a significant jump from 13th place in 2022. As part of our ongoing commitment to driving excellence in the […]
Hamilton Locke Advises EMVision on $15.28M Strategic Placement with Keysight Technologies
Hamilton Locke is pleased to have advised EMVision Medical Devices Limited (ASX: EMV) on its $15.28 million strategic placement with Keysight Technologies Inc (NYSE: KEYS). The deal represents a significant milestone for EMVision, positioning the company for accelerated growth, market penetration, and continued innovation in medical imaging technology. The investment will facilitate and fund EMVision’s […]
